期刊文献+

“三阴”型与非“三阴”型乳腺癌临床特征与E-钙黏蛋白表达的临床意义 被引量:1

Clinical significance of "three negative" and non-"three negative" breast carcinoma clinical features and E-cadherin protein expression
下载PDF
导出
摘要 目的通过回顾性分析总结"三阴"型乳腺癌与非"三阴"型乳腺癌患者的临床病理特征、生物学特点以及两组E-钙黏蛋白表达情况来探讨其表达与乳腺癌转移及预后的相关性,以指导临床对于预后的判断。方法随机抽取笔者所在医院收治的经病理组织学确诊的乳腺癌患者病理组织113例,所有资料临床数据可溯源,且随访完整。采用统计软件对"三阴"型与"非三阴"型乳腺癌患者的临床病理学特点、复发转移、月经状况、E-钙黏蛋白表达等方面进行分析。结果"三阴"型与非三阴型乳腺癌患者相比,E-钙黏蛋白表达无明显统计学差异。但E-钙黏蛋白低表达者,生存曲线有下降趋势。logistic回归分析显示E-钙黏蛋白表达与腋窝淋巴结早期转移、远处转移部位多少、绝经状态以及ER表达状态差异有统计学意义(P<0.05);同时用COX风险模型多因素分析显示,本组患者腋窝淋巴结数目、远处转移部位多少为三阴及非三阴性乳腺癌预后不良的独立危险因素。Kaplan-Meier生存曲线显示ER阳性且E-钙黏蛋白低表达的非三阴乳腺癌生存时间缩短,差异有统计学意义(P<0.05)。结论"三阴"型乳腺癌与非"三阴"型乳腺癌E-钙黏蛋白表达低者预示生存时间缩短,同时E-钙黏蛋白表达与ER表达呈负相关性(P<0.05)。E-钙黏蛋白表达对于乳腺癌预后具有指导性意义。 Objective To explore the connection between E-cadherin’s expression and breast cancer metastasis and prognosis,through retrograde analytic summary the clinical pathologic feature and biological feature of triple-negative breast cancer and non-triple-negative breast cancer,and the E-cadherin expression of the two groups,to guide clinical evaluation of prognosis.Methods 113 cases of breast cancer pathologic tissues in the author’s hospital were randomly selected and had been diagnosed by histopathology.All the clinical datum had the origin and had get the full follow-up.Using analytic software to analyze the clinical pathologic feature regress and metastasis,menstruation,expression of E-cadherin of both TNBC and NTNBC.Results The E-candherin expression between the two groups had no significant difference.But the patients who had low express of E-cadherin,their survival curve on a downward trend.Logistic retrograde analysis showed that the expression of E-cadherin and armpit lymph node number,the number of long-term metastasis,menopause and ER expression condition had significant relation and there had analytic significance(P 〈 0.05).At the same time,the COX risk model muti-factor analysis showed that:all above factors were the isolate risk factors for the poor-prognosis of both TNBC and NTNBC.Kaplan-Meier life curve showed that the NTNBC whose estrogen receptor was negative and had alow expression of E-cadherin had shorter life time.And the difference had analytic significance(P 〈 0.05).Conclusion Both TNBC and NTNBC who have lower expression of E-cadherin mean that the shorten survival time,and the expression of E-cadherin has negative relation with the ER expression.
出处 《中国医药科学》 2012年第15期26-28,共3页 China Medicine And Pharmacy
基金 广东省汕头市重点科技课题立项(医疗卫生)重点项目(E200900185)
关键词 E-钙黏蛋白 乳腺癌 三阴 非三阴 Breast Cancer E-cadherin Ttriple-negative breast cancer Non-triple-negative breast cancer
  • 相关文献

参考文献10

  • 1陈蕾,徐绮腻,郑瑾,林佩娟,张舜芬.乳腺癌临床特征与预后分析[J].中华肿瘤防治杂志,2007,14(15):1159-1162. 被引量:8
  • 2Martin Gttel, Christian Kersting, Isabel Radke, et al.An expssion signature of syndecan-1 ( CD138 ), E-cadhcrin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ[J].Breast Cancer Research, 2007,9 ( 1 ) : 1-12.
  • 3Carey LA, Perou CM, Livasy CA, et al.Race, breast in subtypes and survival the carolina breast cancer[J]. JAM, 2006,295 ( 21 ) : 2492-2502.
  • 4Harris L, Fritsch H, Mennel R, et al.American society of clinical oncology 2007 update of recommendation for the use of tumor markers in breast cancer[J]. J Clin 0neol,2007,25 ( 33 ): 5287-5312.
  • 5Jackson SP.Detecting, signalling and repairing DNA double-strand breaks[J]. Biochem Soc Trans,2001,29 ( Pt6 ) : 655-661.
  • 6Reinhold WC, Reimers MA, Lorenzi P, et al.Multifaetorial regulation of E-eadherin expression : a integrative study.Mol Cancer Ther, 2010,9 ( 1 ) : 1 - 16.
  • 7I Schmalhofer O, Brabletz S, Brabletz T.E-cadherin, beta-catenin and ZEB1 in mahgnant pmgressionofcancer[J].CancerMetasisRev,2009,28 ( 1-2): 151-166.
  • 8Rakha EA, Abd El Rehim D, Pinder SE, et al.Ellis IO: E-cadherin expression in invasive non-lobuIar carcinoma of the breast and its prognostic significance[J].Histopathology, 2005,46: 685-693,.
  • 9Asgei~son KS, Jonasson JG, Tryggvadottir L, et al.Ogmundsdottir/riM: Altered expression of E-cadherin in breast cancer.patterns, mechanisms and clinical significance[J].Eur J Cancer, 2000,36 : 1098-1106.
  • 10Yoshida R, Kimura N, Harada Y, et al.The loss of E-cadherin, alpha-and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer[J].Int J Oncol,2001,18 : 513-520.

二级参考文献9

  • 1赵卫红,徐兵河.淋巴结阳性乳腺癌的术后辅助化疗研究进展[J].癌症进展,2005,3(3):232-236. 被引量:6
  • 2徐兵河.乳腺癌内分泌治疗的现状与展望[J].中华肿瘤防治杂志,2006,13(3):161-164. 被引量:12
  • 3Rouzier R,Extra J M,Klijanienko J,et al.Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes[J].J Clin Oncol,2002,20(5):1304-1310.
  • 4Banerjee M,George J,Song E Y,et al.Tree-based model for breast cancer prognostication[J].J Oncol,J Clin Oncol,2004,22(13):2567-2575.
  • 5Olirotto I A,Chua B,Allan S J,et al.Long-term survival of Patients with supraclavicular metastases at diagnosis of breast cancer[J].J Clin Oncol,2003,21(5):851-854.
  • 6Weir L,Speers C,D'yachkova Y,et al.Prognostic significance of the number of axillary lymph nodes removed in Patients with node-negative breast cancer[J].J Clin Oncol,2002,20(7):1793-1799.
  • 7Jean F,Robert Gray,Lynn G,et al.Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer:results from the eastern cooperative oncology group companion study,EST 4189[J].J Clin Oncol,2000,18(10):2059-2069.
  • 8Henderson I C,Berry D A,Demetri G D,et al.Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer[J].J Clin Oncol,2003,21(6):976-983.
  • 9廖宁,王坤,吴一龙.NCCN乳腺癌临床指引(2003.2版)[J].循证医学,2003,3(3):167-192. 被引量:8

共引文献7

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部